Affiliations 

  • 1 Head and Neck Cancer Research Team, Cancer Research Malaysia, Head and Neck Cancer Research Team, Subang Jaya, Selangor, Malaysia
  • 2 Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom
  • 3 Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, United States
  • 4 Oncology R&D AstraZeneca, CRUK Cambridge Institute, Cambridge, United Kingdom
Elife, 2020 09 29;9.
PMID: 32990596 DOI: 10.7554/eLife.57761

Abstract

New therapeutic targets for oral squamous cell carcinoma (OSCC) are urgently needed. We conducted genome-wide CRISPR-Cas9 screens in 21 OSCC cell lines, primarily derived from Asians, to identify genetic vulnerabilities that can be explored as therapeutic targets. We identify known and novel fitness genes and demonstrate that many previously identified OSCC-related cancer genes are non-essential and could have limited therapeutic value, while other fitness genes warrant further investigation for their potential as therapeutic targets. We validate a distinctive dependency on YAP1 and WWTR1 of the Hippo pathway, where the lost-of-fitness effect of one paralog can be compensated only in a subset of lines. We also discover that OSCCs with WWTR1 dependency signature are significantly associated with biomarkers of favorable response toward immunotherapy. In summary, we have delineated the genetic vulnerabilities of OSCC, enabling the prioritization of therapeutic targets for further exploration, including the targeting of YAP1 and WWTR1.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.